| 1 |
张思为. 丙酸氟替卡松吸入气雾剂联合白三烯受体拮抗剂治疗支气管哮喘患儿的疗效及安全性分析[J]. 首都食品与医药，2020, 12(3): 96-99.
|
| 2 |
Haktanir AM, Phipatanakul W. Severe asthma in children: Evaluation and management [J]. Allergol Int, 2019, 68(2): 150-157.
|
| 3 |
李 莎，舒秀兰. 小儿肺热咳喘颗粒联合丙酸氟替卡松治疗小儿支气管哮喘疗效及对IL-6，IL-8及TNF-α水平的影响[J]. 中华中医药学刊，2021, 39(3): 237-240.
|
| 4 |
姚友东，谢水娟，汪茂昌，等. 孟鲁斯特联合糖皮质激素治疗小儿支气管哮喘的临床疗效和安全性分析[J]. 现代诊断与治疗，2019, 15(12): 2015-2016.
|
| 5 |
Trinh H, Lee SH, Cao T, et al. Asthma pharmacotherapy: an update on leukotriene treatments[J]. Expert Rev Respir Med, 2019, 13(12): 1169-1178.
|
| 6 |
中华医学会儿科学分会呼吸学组，《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志，2016, 54(3): 167-181.
|
| 7 |
王秀娟，叶金丹，陆卫民. 影响儿童支气管哮喘急性发作的危险因素调查分析[J]. 中国妇幼保健，2020, 35(4): 720-722.
|
| 8 |
Hoch HE, Houin PR, Stillwell PC. Asthma in Children: A brief review for primary care providers[J]. Pediatr Ann, 2019, 48(3): e103-e109.
|
| 9 |
Ahmed H, Turner S. Severe asthma in children-a review of definitions，epidemiology, and treatment options in 2019[J]. Pediatr Pulmonol, 2019, 54(6): 778-787.
|
| 10 |
Poowuttikul P, Saini S, Seth D. Inner-city asthma in children [J]. Clin Rev Allergy Immunol, 2019, 56(2): 248-268.
|
| 11 |
范小丽，魏 敏，苏 曼. 基于快乐理念的干预模式对哮喘患儿心理弹性及生活质量的影响[J/CD]. 中华肺部疾病杂志(电子版) 2021, 14(1): 90-92.
|
| 12 |
刘亚军，魏 兵，廖世峨，等. CHRM1基因多态性与儿童哮喘易感性及肺功能，血清乙酰胆碱水平的分析[J]. 国际儿科学杂志，2021, 48(12): 853-858.
|
| 13 |
杨斯博. 细菌溶解产物联合沙美特罗替卡松在支气管哮喘患儿中的应用效果[J]. 中国微生态学杂志，2020, 32(6): 5-11.
|
| 14 |
杜文琼，彭小利，朱晓琴，等. 小儿肺热清颗粒联合丙酸氟替卡松对小儿支气管哮喘患儿的临床疗效[J]. 中成药，2019, 41(2): 313-316.
|
| 15 |
陶 磊. 丙酸氟替卡松联合小儿肺咳颗粒治疗儿童支气管哮喘的临床疗效及炎性因子[J]. 现代消化及介入诊疗，2020, 12(4): 6-13.
|
| 16 |
马 薇，吕竹芬，陈燕忠. 星点设计-效应面法优化普仑司特自微乳给药系统[J]. 中国新药杂志，2016, 25(10): 1153-1159.
|
| 17 |
Velázquez-Quesada I, Ruiz-Moreno AJ, Casique-Aguirre D, et al. Pranlukast antagonizes CD49f and reduces stemness in triple-negative breast cancer cells[J]. Drug Des Devel Ther, 2020, 14(21): 1799-1811.
|
| 18 |
Biagioli M, Carino A, Marchiano S, et al. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1[J]. Biochem Pharmacol, 2020, 177(36): 87-93.
|
| 19 |
Saglani S, Fleming L, Sonnappa S, et al. Advances in the aetiology, management, and prevention of acute asthma attacks in Children [J]. Lancet Child Adolesc Health, 2019, 3(5): 354-364.
|
| 20 |
Meshram D, Bhardwaj K, Rathod C, et al. The role of leukotrienes inhibitors in the management of chronic inflammatory diseases[J]. Recent Pat Inflamm Allergy Drug Discov, 2020, 14(1): 15-31.
|
| 21 |
Kalyankar GG, Desai PN, Prajapati PB, et al. Development and validation of stability-indicating RP-HPLC method for estimation of pranlukast hydrate in its laboratory mixture [J]. J Chromatogr Sci, 2021, 37(12): 8-14.
|
| 22 |
Tamai E, Yasu T, Hikita E, et al. Elevated prothrombin time and international normalized ratio caused by drug-drug interactions between warfarin and pranlukast[J]. Am J Ther, 2021, 25(8): 35-39.
|
| 23 |
Biagini MJ, Schauberger E, He H, et al. A pediatric asthma risk score to better predict asthma development in young Children[J]. J Allergy Clin Immunol, 2019, 143(5): 1803-1810.
|
| 24 |
Hoch H, Kattan M, Szefler SJ. Challenges in managing difficult-to-treat asthma in children: Stop, look, and listen[J]. Pediatr Pulmonol, 2020, 55(3): 791-794.
|
| 25 |
韩林华，王 婧，周 翔. 定喘汤穴位贴敷对哮喘急性发作EOS、总IgE及肺功能的影响[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(5): 647-649.
|
| 26 |
冯 琼，明 静，林明静，等. 寒喘祖帕颗粒联合丙酸氟替卡松治疗小儿支气管哮喘疗效及对ICAM-1，EOS，IgE水平影响[J]. 中华中医药学刊，2020, 38(12): 196-200.
|